Clinical TrialsSearch results
Number of results: 2568
Recruiting
- The prospective trial of patient-proposed healthcare services with multiple targeted agent based on gene profiling.
- Solid Tumor
- Yamamoto Noboru
- 2019-10-01
Not yet recruiting
- A study of changes in urinary rocuronium concentration after continuous administration of rocuronium during hepatic blood flow interruption in liver resection surgery.
- Patients undergoing hepatectomy
- Yamamoto Mai
- 2024-02-15
Recruiting
- A Study to Test the Effect of BI 456906 on Cardiovascular Safety in People With Overweight or Obesity
- Obesity
- Yamamoto Machiko
- 2023-11-25
Not yet recruiting
- Efficacy and safety of ARM-P (Anti-reflux mucoplasty)
- Drug-resistant/dependent gastroesophageal reflux disease (GERD)
- Yamamoto Kazuki
- 2023-07-14
Other
- JCOG0908: Randomized phase II study of biweekly R-CHOP versus biweekly R-CHOP followed by CHASER as induction therapy for high-dose chemotherapy, LEED, and autologous stem-cell transplantation in poor-risk diffuse large B-cell lymphoma
- DLBCL, including subtype; lymphomatoid granulomatosis(G3); primary mediastinal large B cell lymphoma
- YAMAMOTO Kazuhito
- 2019-02-04
Other
- Multicenter Trial of autologous nasal mucosal epithelial cell sheets for chronic middle ear inflammatory disease (middle ear cholesteatoma)
- Chronic middle ear inflammatory disease (middle ear cholesteatoma)
- Yamamoto Kazuhisa
- 2021-11-22
Other
- Randomized phase 3 trial of prophylactic cranial irradiation for patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer patients with no brain metastasis who had a response to platinum-based first-line chemotherapy,
- Yamamoto Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-03-05
Recruiting
- Bintrafusp Alfa Program Rollover Study
- Cancer
- Yamaki Masataka
- 2022-01-19
Other
- Open-label, Multicenter Trial of M1774 (DDRiver Solid Tumors 301)
- Metastatic or Locally Advanced Unresectable Solid Tumors
- Yamaki Masataka
- 2022-09-08
Other
- An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients with Advanced Solid Malignancies
- Advanced solid malignancies
- Yamaji Shigeyuki
- 2022-06-01